This is a report of a 10-year-old girl with congenital hemihypertrophy (CH) associated with medullary sponge kidney (MSK) and adrenocortical adenoma. Computed tomography (CT) and ultrasonography demonstrated a small, non-functional, adrenocortical adenoma. A search of the literature failed to reveal any previously reported case having all three conditions. A 10-year-old Japanese girl was admitted with fever, headache and vomiting of 2 days duration. She was born without complications after full-term pregnancy with a birth weight of 3750 g. Slight asymmetry of her legs was noted at birth. Her development was normal and there was no family history of renal disease. On admission, slight hypertrophy of the left lower extremity was noted and the left thigh was 3.0 cm greater in girth than the right.

Ultrasonography was performed for 15 patients with gastric ulcers, after tap water ingestion using 5‐MHz and/or 7.5‐MHz transducers. Sonographic signs of gastric ulcer were classified as gastric wall edema associated with ulcer crater (six cases) and gastric wall edema only (nine cases). The latter nine included two cases of perforation of gastric ulcers that were depicted as gastric wall edema associated with fluid collection. Ultrasonography proved useful for detecting benign ulcerations and can be used to supplement follow‐up examinations, but it cannot replace endoscopy and contrast radiography.

No abstract

No abstract

We treated in total 795 patients with primary transitional cell carcinoma of the urinary bladder between April, 1964 and December, 1988. Eighteen patients of them had upper urothelial cancer during the follow-up period. Thirteen of the 18 patients had received transurethral resection for the initial bladder cancer, while 3 total cystectomy and 2 segmental resection. The over-all incidence of bladder cancer patients who subsequently developed upper urinary tract tumors was 2.3 per cent. The interval between initial treatment of the bladder cancer and treatment for the upper urinary tract tumor ranged from 2 to 74 months (median 20 months). The five-year survival rate after treatment for the upper urinary tract tumor was 31.7 per cent. We conclude that the following are high risk patients for development of upper urinary tract recurrences: 1) patients with bladder cancer near orifices, 2) patients with recurrent bladder cancer under bladder preserving treatment for a long time, 3) patients with G2 multifocal bladder cancer.